Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 1 hour ago
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
about 1 hour ago
Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis...
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
about 2 hours ago
In vivo gene editing outfit Scribe Therapeutics has priced its IPO at...
Scancell to go public after winning reverse merger bid for troubled Neuphoria
about 20 hours ago
Scancell and Neuphoria have made their union official via a reverse merger...
Roche Diagnostics growth remains muted amid China headwinds
about 21 hours ago
Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase...
Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear
about 21 hours ago
Eli Lilly’s triple-G drug retatrutide has hit the primary endpoints of a...
FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’
about 22 hours ago
The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as...
Australian biopharma Clinuvel to shed up to 20% of workforce in move to US
1 day ago
Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.— but...
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
1 day ago
Roche may have scrapped work on a T-cell engager being evaluated for...
‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins
1 day ago
A string of recent wins on the frontiers of novel drug development...
NIH joins Trump’s $5B AI mission with biomedical research push
1 day ago
The U.S. Department of Health and Human Services announced new efforts Wednesday...
Celldex ends skin disease program after failing phase 2 test
2 days ago
A phase 2 study of Celldex’s barzolvolimab in a chronic skin disease...
House passes bill directing FDA to update animal testing rules
2 days ago
The U.S. House of Representatives passed the FDA Modernization Act 3.0 this...